References
- Wang J. G., Liu G., Wang X., Zhang S., Sun M., Pan X., Jian M., Gong L., Thijs L., Staessen J., Fagard R., Liu L. on behalf of the Syst-China Investigators. Long-term blood pressure control in older Chinese patients with isolated systolic hypertension: a progress report on the Syst-China trial. J Hum Hypertens 1996; 10: 735–742
- Liu L., Wang J. G., Gong L., Liu G., Staessen JA. for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens 1998; 16, in press.
- SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–3264
- The Systolic Hypertension in the Elderly Program Cooperative Research Group. Implications of the systolic hypertension in the elderly program. Hypertension 1993; 21: 335–343
- Staessen J. A., Fagard R., Thijs L., Celis H., Arabidze Birkenhá G. G., Uger W. H., de Bulpitt C. J., Leeuw P. W., Dollery C. T., Fletcher A. E., Forette F., Leonetti G., Nachev C., O'Brien E. T., Rosenfeld J., Rodicio J., Tuomilehto J., Zanchetti A. for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757–764
- Staessen J. A., Fagard R., Thijs L., Celis Birkenhá H., Uger W. H., Bulpitt C. J., de Leeuw P. W., Fletcher A. E., Babarskiene M. R., Forette F., Kocemba J., Laks T., Leonetti G., Nachev C., Petrie J. C., Tuomilehto J., Vanhanen H., Webster J., Yodfat Y., Zanchetti A. for the Systolic Hypertension in Europe Trial Investigators. Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly. Arch Intern Med 1998; 158: 1681–1691
- He J., Klag M. J., Wu Z., Whelton PK. Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. Stroke 1995; 26: 2222–2227
- Wu K., Xie L., Chen D., Chen J. The natural history of borderline hypertension in a Chinese population. J Hum Hypertens 1997; 11: 95–100
- He J., Klag M. J., Wu Z., Whelton PK. Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. Stroke 1995; 26: 2228–2232